| 摘要 |
The present invention provides a method of treating a patient suffering from post radical prostatectomy erectile dysfunction (ED RP), in particular iatrogenic reversible erectile dysfunction post radical prostatectomy, comprising the administration of a therapeutically effective amount of a vasoactive intestinal peptide (VDP) and a therapeutically effective amount of an alpha-adrencrgic blocker. Generally the VIP is in the form of a composition having a pH of from around 6 to around 9. |
